A single 120 microgram dose of the vaccine generated strong neutralizing antibodies against both subtypes of RSV, called RSV-A and RSV-B, across all groups...
- Pfizer said on Monday its respiratory syncytial virus vaccine Abrysvo generated a strong immune response in a late-stage study of four groups of adults aged 18 and older with a compromised immune system.
Pfizer's vaccine is currently approved for people aged 60 and older and for use in women during the middle of the third trimester of pregnancy to protect their babies. Trump vs Harris live: Harris raises $12m in California fundraiser as Elon Musk to interview Trump live on X Global Manga Market Global Manga Market Dublin, Aug. 12, 2024 -- The "Manga - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Manga is estimated at US$14.7 Billion in 2023 and is projected to reach US$42.0 Billion by 2030, growing at a CAGR of 16.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Compromised Immune System Older Adults Respiratory Syncytial Virus Vaccine
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer's RSV vaccine shows benefit in immuno-compromised adults in studyA single 120 microgram dose of the vaccine generated strong neutralizing antibodies against both subtypes of RSV, called RSV-A and RSV-B, across all groups...
Read more »
Massachusetts governor says Steward Health Care must give 120-day notice before closing hospitalsBOSTON (AP) — Gov. Maura Healey said Thursday she is pressing Steward Health Care to adhere to a state Department of Public Health regulation that hospital...
Read more »
Calgary bike race and street festival a celebration of Bowness’ resiliencyAbout 120 vendors set up shop while more than 200 cyclists participated in the road race.
Read more »
BEYOND LOCAL: Ontario expanding access to RSV vaccines for children, pregnant womenProvince says infants and high-risk children up to two years old will have access to new immunization to protect against respiratory syncytial virus
Read more »
Ontario offering RSV vaccines to more young children and to pregnant womenOntario is expanding its respiratory virus vaccination program this year for infants, high-risk children and pregnant women ahead of the fall flu season.
Read more »
Ontario expanding access to RSV vaccines for young children, pregnant womenChief Medical Officer of Health Dr. Kieran Moore says the changes should better protect young children from severe outcomes
Read more »